Herpes infections may be a side effect of the COVID-19 vaccine, experts have revealed.
Scientists in Israel identified six cases in a new study of patients developing a skin rash known as herpes zoster after receiving the Pfizer vaccine, according to a study in the Rheumatology journal.
Herpes zoster starts off as a small, itchy skin rash, but if left untreated, it could cause nerve damage and pain, the Jerusalem Post reported.
This can include a prolonged burning sensation on the skin even after the rash disappears.
Researchers from Tel Aviv Sourasky Medical Center and Carmel Medical Center in Haifa found those with autoimmune inflammatory rheumatic diseases had a higher risk of developing the herpes
Individuals who have been “fully vaccinated” with the Pfizer vaccine may need to receive a third shot in the near future, Pfizer CEO Albert Bourla stated this month.
“It is extremely important to suppress the pool of people that can be susceptible to the virus,” Bourla told CNBC’s Bertha Coombs, floating the possibility of annual vaccinations for the Chinese coronavirus.His remarks follow Pfizer and BioNTech outlining their intention to test a third dose of the vaccine — an announcement made in February.
“We believe that the third dose will raise the antibody response 10- to 20- fold,” Bourla said at the time, likening it to the annual flu shot.
“Every year, you need to go to get your flu vaccine,” Bourla said. “It’s going to be the same with COVID. In a year, you will have to go and get your annual shot for Covid to be protected.”
Dr. Anthony Fauci has already previewed the possibility of coronavirus booster shots, explaining people “very well may need to get booster shots to keep up the level of protection.”
“We need to be careful about that six-month number. The study only went out as far as six months. We know for sure it’s effective for six months, but highly likely that it will be effective for considerably longer period of time,” he said during an appearance on The Mehdi Hasan Show.
Back in 1999, leading U.S. Food and Drug Administration (FDA) official Dr. Peter Patriarca contended that modern advances in vaccine technology were rapidly “outpacing researchers’ ability to predict potential vaccine-related adverse events.” Patriarca mused that this could lead to “a situation of unforeseen and unpredictable vaccine outcomes.”
In a new research article published in Microbiology & Infectious Diseases, veteran immunologist J. Bart Classen expresses similar concerns and writes that “RNA-based COVID vaccines have the potential to cause more disease than the epidemic of COVID-19.”
For decades, Classen has published papers exploring how vaccination can give rise to chronic conditions such as Type 1 and Type 2 diabetes — not right away, but three or four years down the road.
In this latest paper, Classen warns that the RNA-based vaccine technology could create “new potential mechanisms” of vaccine adverse events that may take years to come to light.
Classen’s study establishes the potential for the messenger RNA (mRNA) vaccines developed by Pfizer and Moderna to activate human proteins to take on “pathologic configurations” — configurations associated with chronic degenerative neurological diseases.
Although his specific interest is in prion diseases (conditions associated with misfolded versions of normal proteins), Classen also outlines a handful of other mechanisms whereby RNA-based vaccines could give rise to “multiple other potential fatal adverse events.”
The CDC has done another data dump into the Vaccine Adverse Event Reporting System (VAERS), a U.S. Government funded database that tracks injuries and deaths caused by vaccines.
The data goes through January 29, 2021, with 11,249 recorded adverse events, including 501 deaths following injections of the experimental COVID mRNA shots by Pfizer and Moderna.
U.S. Rep. Stephen Lynch, D-Mass., has tested positive for COVID-19, his office announced Friday.
Lynch, who had already received both doses of Pfizer’s coronavirus vaccine, was tested for the virus after a staff member in his Boston office tested positive earlier in the week. The congressman received his positive test Friday afternoon.
Lynch’s office says that he did continue to follow COVID-19 safety protocols, such as social distancing and wearing a mask, even after receiving the vaccine.
A statement from Pfizer said that it can take seven days for protection from the second dose to kick in. However, the statement from Lynch’s office said the congressman received the second dose vaccine before attending President Joe Biden’s inauguration on Jan. 20, nine days before his positive test.
Lynch, who represents the state’s 8th Congressional District, also tested negative for COVID-19 prior to the inauguration.
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.
India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December. The regulator has also declined to accept the company’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.